Global Microneedle-based Drug Delivery System Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026

  • receipt Report ID : 197060
  • calendar_today Published On: Mar, 2021
  • file_copy Pages: 156
  • list Medical Devices
Buy @ $3500

The Microneedle-based Drug Delivery System market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Microneedle-based Drug Delivery System size is estimated to be xx million in 2021 from USD xx million in 2020, with a change of XX% between 2020 and 2021. The global Microneedle-based Drug Delivery System market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation

Microneedle-based Drug Delivery System market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers

Hollow Microneedle Technology

Solid Microneedle Technology

Dissolving Microneedles Technology

Market segment by Application can be divided into

Drug Delivery

Vaccine Delivery

Other

The key market players for global Microneedle-based Drug Delivery System market are listed below:

3M

Zosano Pharma

Becton-Dickinson(BD)Technologies

Nanopass Technologies

Corium

Valeritas

Nitto

Microdermics

TheraJect

Vaxxas

Lohmann Therapie-Systeme AG

Market segment by Region, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)

South America (Brazil, Argentina, Colombia, and Rest of South America)

Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 14 chapters:

Chapter 1, to describe Microneedle-based Drug Delivery System product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top manufacturers of Microneedle-based Drug Delivery System, with price, sales, revenue and global market share of Microneedle-based Drug Delivery System in 2018 and 2019.

Chapter 3, the Microneedle-based Drug Delivery System competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Microneedle-based Drug Delivery System breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.

Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.

Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Microneedle-based Drug Delivery System market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.

Chapter 12, 13 and 14, to describe Microneedle-based Drug Delivery System sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Market Overview

1.1 Microneedle-based Drug Delivery System Introduction

1.2 Market Analysis by Type

1.2.1 Overview: Global Microneedle-based Drug Delivery System Revenue by Type: 2019 Versus 2021 Versus 2026

1.2.2 Hollow Microneedle Technology

1.2.3 Solid Microneedle Technology

1.2.4 Dissolving Microneedles Technology

1.3 Market Analysis by Application

1.3.1 Overview: Global Microneedle-based Drug Delivery System Revenue by Application: 2019 Versus 2021 Versus 2026

1.3.2 Drug Delivery

1.3.3 Vaccine Delivery

1.3.4 Other

1.4 Global Microneedle-based Drug Delivery System Market Size & Forecast

1.4.1 Global Microneedle-based Drug Delivery System Sales in Value (2016-2026))

1.4.2 Global Microneedle-based Drug Delivery System Sales in Volume (2016-2026)

1.4.3 Global Microneedle-based Drug Delivery System Price by Type (2016-2026) & (US$/Unit)

1.5 Global Microneedle-based Drug Delivery System Production Capacity Analysis

1.5.1 Global Microneedle-based Drug Delivery System Total Production Capacity (2016-2026)

1.5.2 Global Microneedle-based Drug Delivery System Production Capacity by Geographic Region

1.6 Market Drivers, Restraints and Trends

1.6.1 Microneedle-based Drug Delivery System Market Drivers

1.6.2 Microneedle-based Drug Delivery System Market Restraints

1.6.3 Microneedle-based Drug Delivery System Trends Analysis

2 Manufacturers Profiles

2.1 3M

2.1.1 3M Details

2.1.2 3M Major Business

2.1.3 3M Microneedle-based Drug Delivery System Product and Services

2.1.4 3M Microneedle-based Drug Delivery System Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.2 Zosano Pharma

2.2.1 Zosano Pharma Details

2.2.2 Zosano Pharma Major Business

2.2.3 Zosano Pharma Microneedle-based Drug Delivery System Product and Services

2.2.4 Zosano Pharma Microneedle-based Drug Delivery System Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.3 Becton-Dickinson(BD)Technologies

2.3.1 Becton-Dickinson(BD)Technologies Details

2.3.2 Becton-Dickinson(BD)Technologies Major Business

2.3.3 Becton-Dickinson(BD)Technologies Microneedle-based Drug Delivery System Product and Services

2.3.4 Becton-Dickinson(BD)Technologies Microneedle-based Drug Delivery System Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.4 Nanopass Technologies

2.4.1 Nanopass Technologies Details

2.4.2 Nanopass Technologies Major Business

2.4.3 Nanopass Technologies Microneedle-based Drug Delivery System Product and Services

2.4.4 Nanopass Technologies Microneedle-based Drug Delivery System Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.5 Corium

2.5.1 Corium Details

2.5.2 Corium Major Business

2.5.3 Corium Microneedle-based Drug Delivery System Product and Services

2.5.4 Corium Microneedle-based Drug Delivery System Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.6 Valeritas

2.6.1 Valeritas Details

2.6.2 Valeritas Major Business

2.6.3 Valeritas Microneedle-based Drug Delivery System Product and Services

2.6.4 Valeritas Microneedle-based Drug Delivery System Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.7 Nitto

2.7.1 Nitto Details

2.7.2 Nitto Major Business

2.7.3 Nitto Microneedle-based Drug Delivery System Product and Services

2.7.4 Nitto Microneedle-based Drug Delivery System Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.8 Microdermics

2.8.1 Microdermics Details

2.8.2 Microdermics Major Business

2.8.3 Microdermics Microneedle-based Drug Delivery System Product and Services

2.8.4 Microdermics Microneedle-based Drug Delivery System Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.9 TheraJect

2.9.1 TheraJect Details

2.9.2 TheraJect Major Business

2.9.3 TheraJect Microneedle-based Drug Delivery System Product and Services

2.9.4 TheraJect Microneedle-based Drug Delivery System Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.10 Vaxxas

2.10.1 Vaxxas Details

2.10.2 Vaxxas Major Business

2.10.3 Vaxxas Microneedle-based Drug Delivery System Product and Services

2.10.4 Vaxxas Microneedle-based Drug Delivery System Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.11 Lohmann Therapie-Systeme AG

2.11.1 Lohmann Therapie-Systeme AG Details

2.11.2 Lohmann Therapie-Systeme AG Major Business

2.11.3 Lohmann Therapie-Systeme AG Microneedle-based Drug Delivery System Product and Services

2.11.4 Lohmann Therapie-Systeme AG Microneedle-based Drug Delivery System Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

3 Microneedle-based Drug Delivery System Sales by Manufacturer

3.1 Global Microneedle-based Drug Delivery System Sales in Volume by Manufacturer (2019-2021e)

3.2 Global Microneedle-based Drug Delivery System Revenue by Manufacturer (2019-2021e)

3.3 Key Manufacturer Market Position in Microneedle-based Drug Delivery System

3.4 Market Concentration Rate

3.4.1 Top 3 Microneedle-based Drug Delivery System Manufacturer Market Share

3.4.2 Top 6 Microneedle-based Drug Delivery System Manufacturer Market Share

3.5 Global Microneedle-based Drug Delivery System Production Capacity by Company

3.6 Manufacturer by Geography: Head Office and Microneedle-based Drug Delivery System Production Site

3.7 New Entrant and Capacity Expansion Plans

3.8 Mergers & Acquisitions

4 Market Analysis by Region

4.1 Global Microneedle-based Drug Delivery System Market Size by Region

4.1.1 Global Microneedle-based Drug Delivery System Sales in Volume by Region (2016-2026)

4.1.2 Global Microneedle-based Drug Delivery System Revenue by Region (2016-2026)

4.2 North America Microneedle-based Drug Delivery System Revenue (2016-2026)

4.3 Europe Microneedle-based Drug Delivery System Revenue (2016-2026)

4.4 Asia-Pacific Microneedle-based Drug Delivery System Revenue (2016-2026)

4.5 South America Microneedle-based Drug Delivery System Revenue (2016-2026)

4.6 Middle East and Africa Microneedle-based Drug Delivery System Revenue (2016-2026)

5 Market Segment by Type

5.1 Global Microneedle-based Drug Delivery System Sales in Volume by Type (2016-2026)

5.2 Global Microneedle-based Drug Delivery System Revenue by Type (2016-2026)

5.3 Global Microneedle-based Drug Delivery System Price by Type (2016-2026)

6 Market Segment by Application

6.1 Global Microneedle-based Drug Delivery System Sales in Volume by Application (2016-2026)

6.2 Global Microneedle-based Drug Delivery System Revenue by Application (2016-2026)

6.3 Global Microneedle-based Drug Delivery System Price by Application (2016-2026)

7 North America by Country, by Type, and by Application

7.1 North America Microneedle-based Drug Delivery System Sales by Type (2016-2026)

7.2 North America Microneedle-based Drug Delivery System Sales by Application (2016-2026)

7.3 North America Microneedle-based Drug Delivery System Market Size by Country

7.3.1 North America Microneedle-based Drug Delivery System Sales in Volume by Country (2016-2026)

7.3.2 North America Microneedle-based Drug Delivery System Revenue by Country (2016-2026)

7.3.3 United States Market Size and Forecast (2016-2026)

7.3.4 Canada Market Size and Forecast (2016-2026)

7.3.5 Mexico Market Size and Forecast (2016-2026)

8 Europe by Country, by Type, and by Application

8.1 Europe Microneedle-based Drug Delivery System Sales by Type (2016-2026)

8.2 Europe Microneedle-based Drug Delivery System Sales by Application (2016-2026)

8.3 Europe Microneedle-based Drug Delivery System Market Size by Country

8.3.1 Europe Microneedle-based Drug Delivery System Sales in Volume by Country (2016-2026)

8.3.2 Europe Microneedle-based Drug Delivery System Revenue by Country (2016-2026)

8.3.3 Germany Market Size and Forecast (2016-2026)

8.3.4 France Market Size and Forecast (2016-2026)

8.3.5 United Kingdom Market Size and Forecast (2016-2026)

8.3.6 Russia Market Size and Forecast (2016-2026)

8.3.7 Italy Market Size and Forecast (2016-2026)

9 Asia-Pacific by Country, by Type, and by Application

9.1 Asia-Pacific Microneedle-based Drug Delivery System Sales by Type (2016-2026)

9.2 Asia-Pacific Microneedle-based Drug Delivery System Sales by Application (2016-2026)

9.3 Asia-Pacific Microneedle-based Drug Delivery System Market Size by Region

9.3.1 Asia-Pacific Microneedle-based Drug Delivery System Sales in Volume by Region (2016-2026)

9.3.2 Asia-Pacific Microneedle-based Drug Delivery System Revenue by Region (2016-2026)

9.3.3 China Market Size and Forecast (2016-2026)

9.3.4 Japan Market Size and Forecast (2016-2026)

9.3.5 Korea Market Size and Forecast (2016-2026)

9.3.6 India Market Size and Forecast (2016-2026)

9.3.7 Southeast Asia Market Size and Forecast (2016-2026)

9.3.8 Australia Market Size and Forecast (2016-2026)

10 South America by Country, by Type, and by Application

10.1 South America Microneedle-based Drug Delivery System Sales by Type (2016-2026)

10.2 South America Microneedle-based Drug Delivery System Sales by Application (2016-2026)

10.3 South America Microneedle-based Drug Delivery System Market Size by Country

10.3.1 South America Microneedle-based Drug Delivery System Sales in Volume by Country (2016-2026)

10.3.2 South America Microneedle-based Drug Delivery System Revenue by Country (2016-2026)

10.3.3 Brazil Market Size and Forecast (2016-2026)

10.3.4 Argentina Market Size and Forecast (2016-2026)

11 Middle East & Africa by Country, by Type, and by Application

11.1 Middle East & Africa Microneedle-based Drug Delivery System Sales by Type (2016-2026)

11.2 Middle East & Africa Microneedle-based Drug Delivery System Sales by Application (2016-2026)

11.3 Middle East & Africa Microneedle-based Drug Delivery System Market Size by Country

11.3.1 Middle East & Africa Microneedle-based Drug Delivery System Sales in Volume by Country (2016-2026)

11.3.2 Middle East & Africa Microneedle-based Drug Delivery System Revenue by Country (2016-2026)

11.3.3 Turkey Market Size and Forecast (2016-2026)

11.3.4 Egypt Market Size and Forecast (2016-2026)

11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)

11.3.6 South Africa Market Size and Forecast (2016-2026)

12 Sales Channel, Distributors, Traders and Dealers

12.1 Sales Channel

12.1.1 Direct Marketing

12.1.2 Indirect Marketing

12.2 Microneedle-based Drug Delivery System Typical Distributors

12.3 Microneedle-based Drug Delivery System Typical Customers

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology

14.2 Research Process and Data Source

14.3 Disclaimer

List of Tables

Table 1. Global Microneedle-based Drug Delivery System Revenue by Type, (USD Million), 2021-2026

Table 2. Global Microneedle-based Drug Delivery System Revenue by Application, (USD Million), 2021-2026

Table 3. 3M Basic Information, Manufacturing Base and Competitors

Table 4. 3M Major Business

Table 5. 3M Microneedle-based Drug Delivery System Product and Services

Table 6. 3M Microneedle-based Drug Delivery System Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 7. Zosano Pharma Basic Information, Manufacturing Base and Competitors

Table 8. Zosano Pharma Major Business

Table 9. Zosano Pharma Microneedle-based Drug Delivery System Product and Services

Table 10. Zosano Pharma Microneedle-based Drug Delivery System Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 11. Becton-Dickinson(BD)Technologies Basic Information, Manufacturing Base and Competitors

Table 12. Becton-Dickinson(BD)Technologies Major Business

Table 13. Becton-Dickinson(BD)Technologies Microneedle-based Drug Delivery System Product and Services

Table 14. Becton-Dickinson(BD)Technologies Microneedle-based Drug Delivery System Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 15. Nanopass Technologies Basic Information, Manufacturing Base and Competitors

Table 16. Nanopass Technologies Major Business

Table 17. Nanopass Technologies Microneedle-based Drug Delivery System Product and Services

Table 18. Nanopass Technologies Microneedle-based Drug Delivery System Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 19. Corium Basic Information, Manufacturing Base and Competitors

Table 20. Corium Major Business

Table 21. Corium Microneedle-based Drug Delivery System Product and Services

Table 22. Corium Microneedle-based Drug Delivery System Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 23. Valeritas Basic Information, Manufacturing Base and Competitors

Table 24. Valeritas Major Business

Table 25. Valeritas Microneedle-based Drug Delivery System Product and Services

Table 26. Valeritas Microneedle-based Drug Delivery System Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 27. Nitto Basic Information, Manufacturing Base and Competitors

Table 28. Nitto Major Business

Table 29. Nitto Microneedle-based Drug Delivery System Product and Services

Table 30. Nitto Microneedle-based Drug Delivery System Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 31. Microdermics Basic Information, Manufacturing Base and Competitors

Table 32. Microdermics Major Business

Table 33. Microdermics Microneedle-based Drug Delivery System Product and Services

Table 34. Microdermics Microneedle-based Drug Delivery System Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 35. TheraJect Basic Information, Manufacturing Base and Competitors

Table 36. TheraJect Major Business

Table 37. TheraJect Microneedle-based Drug Delivery System Product and Services

Table 38. TheraJect Microneedle-based Drug Delivery System Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 39. Vaxxas Basic Information, Manufacturing Base and Competitors

Table 40. Vaxxas Major Business

Table 41. Vaxxas Microneedle-based Drug Delivery System Product and Services

Table 42. Vaxxas Microneedle-based Drug Delivery System Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 43. Lohmann Therapie-Systeme AG Basic Information, Manufacturing Base and Competitors

Table 44. Lohmann Therapie-Systeme AG Major Business

Table 45. Lohmann Therapie-Systeme AG Microneedle-based Drug Delivery System Product and Services

Table 46. Lohmann Therapie-Systeme AG Microneedle-based Drug Delivery System Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 47. Global Microneedle-based Drug Delivery System Sales by Manufacturer (2019-2021e) & (K Units)

Table 48. Global Microneedle-based Drug Delivery System Revenue by Manufacturer (2019-2021e) & (USD Million)

Table 49. Market Position of Manufacturers in Microneedle-based Drug Delivery System, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020

Table 50. Global Microneedle-based Drug Delivery System Production Capacity by Company, (K Units): 2020 VS 2021

Table 51. Head Office and Microneedle-based Drug Delivery System Production Site of Key Manufacturer

Table 52. Microneedle-based Drug Delivery System New Entrant and Capacity Expansion Plans

Table 53. Microneedle-based Drug Delivery System Mergers & Acquisitions in the Past Five Years

Table 54. Global Microneedle-based Drug Delivery System Sales by Region (2016-2021e) & (K Units)

Table 55. Global Microneedle-based Drug Delivery System Sales by Region (2021-2026) & (K Units)

Table 56. Global Microneedle-based Drug Delivery System Revenue by Region (2016-2021e) & (USD Million)

Table 57. Global Microneedle-based Drug Delivery System Revenue by Region (2021-2026) & (USD Million)

Table 58. Global Microneedle-based Drug Delivery System Sales by Type (2016-2021e) & (K Units)

Table 59. Global Microneedle-based Drug Delivery System Sales by Type (2021-2026) & (K Units)

Table 60. Global Microneedle-based Drug Delivery System Revenue by Type (2016-2021e) & (USD Million)

Table 61. Global Microneedle-based Drug Delivery System Revenue by Type (2021-2026) & (USD Million)

Table 62. Global Microneedle-based Drug Delivery System Price by Type (2016-2021e) & (US$/Unit)

Table 63. Global Microneedle-based Drug Delivery System Price by Type (2021-2026) & (US$/Unit)

Table 64. Global Microneedle-based Drug Delivery System Sales by Application (2016-2021e) & (K Units)

Table 65. Global Microneedle-based Drug Delivery System Sales by Application (2021-2026) & (K Units)

Table 66. Global Microneedle-based Drug Delivery System Revenue by Application (2016-2021e) & (USD Million)

Table 67. Global Microneedle-based Drug Delivery System Revenue by Application (2021-2026) & (USD Million)

Table 68. Global Microneedle-based Drug Delivery System Price by Application (2016-2021e) & (US$/Unit)

Table 69. Global Microneedle-based Drug Delivery System Price by Application (2021-2026) & (US$/Unit)

Table 70. North America Microneedle-based Drug Delivery System Sales by Country (2016-2021e) & (K Units)

Table 71. North America Microneedle-based Drug Delivery System Sales by Country (2021-2026) & (K Units)

Table 72. North America Microneedle-based Drug Delivery System Revenue by Country (2016-2021e) & (USD Million)

Table 73. North America Microneedle-based Drug Delivery System Revenue by Country (2021-2026) & (USD Million)

Table 74. North America Microneedle-based Drug Delivery System Sales by Type (2016-2021e) & (K Units)

Table 75. North America Microneedle-based Drug Delivery System Sales by Type (2021-2026) & (K Units)

Table 76. North America Microneedle-based Drug Delivery System Sales by Application (2016-2021e) & (K Units)

Table 77. North America Microneedle-based Drug Delivery System Sales by Application (2021-2026) & (K Units)

Table 78. Europe Microneedle-based Drug Delivery System Sales by Country (2016-2021e) & (K Units)

Table 79. Europe Microneedle-based Drug Delivery System Sales by Country (2021-2026) & (K Units)

Table 80. Europe Microneedle-based Drug Delivery System Revenue by Country (2016-2021e) & (USD Million)

Table 81. Europe Microneedle-based Drug Delivery System Revenue by Country (2021-2026) & (USD Million)

Table 82. Europe Microneedle-based Drug Delivery System Sales by Type (2016-2021e) & (K Units)

Table 83. Europe Microneedle-based Drug Delivery System Sales by Type (2021-2026) & (K Units)

Table 84. Europe Microneedle-based Drug Delivery System Sales by Application (2016-2021e) & (K Units)

Table 85. Europe Microneedle-based Drug Delivery System Sales by Application (2021-2026) & (K Units)

Table 86. Asia-Pacific Microneedle-based Drug Delivery System Sales by Region (2016-2021e) & (K Units)

Table 87. Asia-Pacific Microneedle-based Drug Delivery System Sales by Region (2021-2026) & (K Units)

Table 88. Asia-Pacific Microneedle-based Drug Delivery System Revenue by Region (2016-2021e) & (USD Million)

Table 89. Asia-Pacific Microneedle-based Drug Delivery System Revenue by Region (2021-2026) & (USD Million)

Table 90. Asia-Pacific Microneedle-based Drug Delivery System Sales by Type (2016-2021e) & (K Units)

Table 91. Asia-Pacific Microneedle-based Drug Delivery System Sales by Type (2021-2026) & (K Units)

Table 92. Asia-Pacific Microneedle-based Drug Delivery System Sales by Application (2016-2021e) & (K Units)

Table 93. Asia-Pacific Microneedle-based Drug Delivery System Sales by Application (2021-2026) & (K Units)

Table 94. South America Microneedle-based Drug Delivery System Sales by Country (2016-2021e) & (K Units)

Table 95. South America Microneedle-based Drug Delivery System Sales by Country (2021-2026) & (K Units)

Table 96. South America Microneedle-based Drug Delivery System Revenue by Country (2016-2021e) & (USD Million)

Table 97. South America Microneedle-based Drug Delivery System Revenue by Country (2021-2026) & (USD Million)

Table 98. South America Microneedle-based Drug Delivery System Sales by Type (2016-2021e) & (K Units)

Table 99. South America Microneedle-based Drug Delivery System Sales by Type (2021-2026) & (K Units)

Table 100. South America Microneedle-based Drug Delivery System Sales by Application (2016-2021e) & (K Units)

Table 101. South America Microneedle-based Drug Delivery System Sales by Application (2021-2026) & (K Units)

Table 102. Middle East & Africa Microneedle-based Drug Delivery System Sales by Country (2016-2021e) & (K Units)

Table 103. Middle East & Africa Microneedle-based Drug Delivery System Sales by Country (2021-2026) & (K Units)

Table 104. Middle East & Africa Microneedle-based Drug Delivery System Revenue by Country (2016-2021e) & (USD Million)

Table 105. Middle East & Africa Microneedle-based Drug Delivery System Revenue by Country (2021-2026) & (USD Million)

Table 106. Middle East & Africa Microneedle-based Drug Delivery System Sales by Type (2016-2021e) & (K Units)

Table 107. Middle East & Africa Microneedle-based Drug Delivery System Sales by Type (2021-2026) & (K Units)

Table 108. Middle East & Africa Microneedle-based Drug Delivery System Sales by Application (2016-2021e) & (K Units)

Table 109. Middle East & Africa Microneedle-based Drug Delivery System Sales by Application (2021-2026) & (K Units)

Table 110. Direct Channel Pros & Cons

Table 111. Indirect Channel Pros & Cons

Table 112. Microneedle-based Drug Delivery System Typical Distributors

Table 113. Microneedle-based Drug Delivery System Typical Customers

List of Figures

Figure 1. Microneedle-based Drug Delivery System Picture

Figure 2. Global Microneedle-based Drug Delivery System Sales Market Share by Type in 2020

Figure 3. Hollow Microneedle Technology

Figure 4. Solid Microneedle Technology

Figure 5. Dissolving Microneedles Technology

Figure 6. Global Microneedle-based Drug Delivery System Sales Market Share by Application in 2020

Figure 7. Drug Delivery

Figure 8. Vaccine Delivery

Figure 9. Other

Figure 10. Global Microneedle-based Drug Delivery System Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026

Figure 11. Global Microneedle-based Drug Delivery System Market Size and Forecast (2016-2026) & (USD Million)

Figure 12. Global Microneedle-based Drug Delivery System Sales (2016-2026) & (K Units)

Figure 13. Global Microneedle-based Drug Delivery System Price by Type (2016-2026) & (US$/Unit)

Figure 14. Global Microneedle-based Drug Delivery System Production Capacity (2016-2026) & (K Units)

Figure 15. Global Microneedle-based Drug Delivery System Production Capacity by Geographic Region: 2020 VS 2021

Figure 16. Microneedle-based Drug Delivery System Market Drivers

Figure 17. Microneedle-based Drug Delivery System Market Restraints

Figure 18. Microneedle-based Drug Delivery System Market Trends

Figure 19. Global Microneedle-based Drug Delivery System Sales Market Share by Manufacturer in 2020

Figure 20. Global Microneedle-based Drug Delivery System Revenue Market Share by Manufacturer in 2020

Figure 21. Microneedle-based Drug Delivery System Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 22. Top 3 Microneedle-based Drug Delivery System Manufacturer (Revenue) Market Share in 2020

Figure 23. Top 6 Microneedle-based Drug Delivery System Manufacturer (Revenue) Market Share in 2020

Figure 24. Global Microneedle-based Drug Delivery System Sales Market Share by Region (2016-2026)

Figure 25. Global Microneedle-based Drug Delivery System Revenue Market Share by Region (2016-2026)

Figure 26. North America Microneedle-based Drug Delivery System Revenue (2016-2026) & (USD Million)

Figure 27. Europe Microneedle-based Drug Delivery System Revenue (2016-2026) & (USD Million)

Figure 28. Asia-Pacific Microneedle-based Drug Delivery System Revenue (2016-2026) & (USD Million)

Figure 29. South America Microneedle-based Drug Delivery System Revenue (2016-2026) & (USD Million)

Figure 30. Middle East & Africa Microneedle-based Drug Delivery System Revenue (2016-2026) & (USD Million)

Figure 31. Global Microneedle-based Drug Delivery System Sales Market Share by Type (2016-2026)

Figure 32. Global Microneedle-based Drug Delivery System Revenue Market Share by Type (2016-2026)

Figure 33. Global Microneedle-based Drug Delivery System Price by Type (2016-2026) & (US$/Unit)

Figure 34. Global Microneedle-based Drug Delivery System Sales Market Share by Application (2016-2026)

Figure 35. Global Microneedle-based Drug Delivery System Revenue Market Share by Application (2016-2026)

Figure 36. Global Microneedle-based Drug Delivery System Price by Application (2016-2026) & (US$/Unit)

Figure 37. North America Microneedle-based Drug Delivery System Sales Market Share by Type (2016-2026)

Figure 38. North America Microneedle-based Drug Delivery System Sales Market Share by Application (2016-2026)

Figure 39. North America Microneedle-based Drug Delivery System Sales Market Share by Country (2016-2026)

Figure 40. North America Microneedle-based Drug Delivery System Revenue Market Share by Country (2016-2026)

Figure 41. United States Microneedle-based Drug Delivery System Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 42. Canada Microneedle-based Drug Delivery System Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 43. Mexico Microneedle-based Drug Delivery System Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 44. Europe Microneedle-based Drug Delivery System Sales Market Share by Type (2016-2026)

Figure 45. Europe Microneedle-based Drug Delivery System Sales Market Share by Application (2016-2026)

Figure 46. Europe Microneedle-based Drug Delivery System Sales Market Share by Country (2016-2026)

Figure 47. Europe Microneedle-based Drug Delivery System Revenue Market Share by Country (2016-2026)

Figure 48. Germany Microneedle-based Drug Delivery System Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 49. France Microneedle-based Drug Delivery System Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 50. United Kingdom Microneedle-based Drug Delivery System Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 51. Russia Microneedle-based Drug Delivery System Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 52. Italy Microneedle-based Drug Delivery System Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 53. Asia-Pacific Microneedle-based Drug Delivery System Sales Market Share by Region (2016-2026)

Figure 54. Asia-Pacific Microneedle-based Drug Delivery System Sales Market Share by Application (2016-2026)

Figure 55. Asia-Pacific Microneedle-based Drug Delivery System Sales Market Share by Region (2016-2026)

Figure 56. Asia-Pacific Microneedle-based Drug Delivery System Revenue Market Share by Region (2016-2026)

Figure 57. China Microneedle-based Drug Delivery System Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 58. Japan Microneedle-based Drug Delivery System Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 59. Korea Microneedle-based Drug Delivery System Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 60. India Microneedle-based Drug Delivery System Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 61. Southeast Asia Microneedle-based Drug Delivery System Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 62. Australia Microneedle-based Drug Delivery System Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 63. South America Microneedle-based Drug Delivery System Sales Market Share by Type (2016-2026)

Figure 64. South America Microneedle-based Drug Delivery System Sales Market Share by Application (2016-2026)

Figure 65. South America Microneedle-based Drug Delivery System Sales Market Share by Country (2016-2026)

Figure 66. South America Microneedle-based Drug Delivery System Revenue Market Share by Country (2016-2026)

Figure 67. Brazil Microneedle-based Drug Delivery System Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 68. Argentina Microneedle-based Drug Delivery System Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 69. Middle East & Africa Microneedle-based Drug Delivery System Sales Market Share by Type (2016-2026)

Figure 70. Middle East & Africa Microneedle-based Drug Delivery System Sales Market Share by Application (2016-2026)

Figure 71. Middle East & Africa Microneedle-based Drug Delivery System Sales Market Share by Country (2016-2026)

Figure 72. Middle East & Africa Microneedle-based Drug Delivery System Revenue Market Share by Country (2016-2026)

Figure 73. Turkey Microneedle-based Drug Delivery System Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 74. Egypt Microneedle-based Drug Delivery System Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 75. Saudi Arabia Microneedle-based Drug Delivery System Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 76. South Africa Microneedle-based Drug Delivery System Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 77. Sales Channel: Direct Channel vs Indirect Channel

Figure 78. Methodology

Figure 79. Research Process and Data Source